Trial Outcomes & Findings for Clinical Evaluation of the CM-1500 in Postoperative Surgery Patients (NCT NCT04706221)

NCT ID: NCT04706221

Last Updated: 2024-03-27

Results Overview

The primary objective is to evaluate changes in the Relative Index (RI) in post-abdominal or pelvic surgery patients (Laparoscopic or Open). The CM-1500 monitors parameters which are indicative of relative changes in fluid volume in adult patients. The Relative Index is an investigational value which utilizes proprietary algorithms to combine the relative changes of each measured parameter into a single value. The Relative Index is graded on a scale where 100 indicates a patient's baseline, and changes up or down from the baseline could be used as potential indicators of fluid gain or loss relative to the baseline, based on the changes of the individually monitored parameters. Per the device's FDA 510(k) clearance, the RI is computed as the weighted summation of the percent change values (signifying the deviation of each parameter from it's baseline value) for its parameters. Change in RI is calculated by subtracting the initial RI value from the final RI value during monitoring.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

200 participants

Primary outcome timeframe

Length of PACU Stay (Range: 46 to 353 minutes)

Results posted on

2024-03-27

Participant Flow

Participant milestones

Participant milestones
Measure
Blood Volume Monitoring - Open Surgery
Monitoring with CM-1500 (Blood volume monitor CM-1500) during Open Surgery
Blood Volume Monitoring - Laparoscopic Surgery
Monitoring with CM-1500 (Blood volume monitor CM-1500) during Laparoscopic Surgery
Overall Study
STARTED
91
109
Overall Study
COMPLETED
75
98
Overall Study
NOT COMPLETED
16
11

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Blood Volume Monitoring Laparoscopic Surgery
n=98 Participants
CM-1500: Blood volume monitor post-laparoscopic surgery
Blood Volume Monitoring - Open Surgery
n=75 Participants
CM-1500: Blood volume monitor post-open surgery
Total
n=173 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=98 Participants
0 Participants
n=75 Participants
0 Participants
n=173 Participants
Age, Categorical
Between 18 and 65 years
70 Participants
n=98 Participants
45 Participants
n=75 Participants
115 Participants
n=173 Participants
Age, Categorical
>=65 years
28 Participants
n=98 Participants
30 Participants
n=75 Participants
58 Participants
n=173 Participants
Age, Continuous
54.1 years
STANDARD_DEVIATION 14.3 • n=98 Participants
58.4 years
STANDARD_DEVIATION 15.2 • n=75 Participants
56.25 years
STANDARD_DEVIATION 14.7 • n=173 Participants
Sex: Female, Male
Female
62 Participants
n=98 Participants
40 Participants
n=75 Participants
102 Participants
n=173 Participants
Sex: Female, Male
Male
36 Participants
n=98 Participants
35 Participants
n=75 Participants
71 Participants
n=173 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
98 Participants
n=98 Participants
75 Participants
n=75 Participants
173 Participants
n=173 Participants

PRIMARY outcome

Timeframe: Length of PACU Stay (Range: 46 to 353 minutes)

The primary objective is to evaluate changes in the Relative Index (RI) in post-abdominal or pelvic surgery patients (Laparoscopic or Open). The CM-1500 monitors parameters which are indicative of relative changes in fluid volume in adult patients. The Relative Index is an investigational value which utilizes proprietary algorithms to combine the relative changes of each measured parameter into a single value. The Relative Index is graded on a scale where 100 indicates a patient's baseline, and changes up or down from the baseline could be used as potential indicators of fluid gain or loss relative to the baseline, based on the changes of the individually monitored parameters. Per the device's FDA 510(k) clearance, the RI is computed as the weighted summation of the percent change values (signifying the deviation of each parameter from it's baseline value) for its parameters. Change in RI is calculated by subtracting the initial RI value from the final RI value during monitoring.

Outcome measures

Outcome measures
Measure
Blood Volume Monitoring - Open Surgery
n=75 Participants
CM-1500: Monitoring with CM-1500 (Blood Volume Monitor CM-1500) during Open Surgery
Blood Volume Monitoring - Laparoscopic Surgery
n=98 Participants
CM-1500: Monitoring with CM-1500 (Blood Volume Monitor CM-1500) during Laparoscopic Surgery
Relative Index Change During PACU Stay
-2.01 Relative Index (RI)
Standard Deviation 4.00
-1.32 Relative Index (RI)
Standard Deviation 3.11

Adverse Events

Blood Volume Monitoring Laparoscopic Surgery

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Blood Volume Monitoring - Open Surgery

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Donald Gregg

Zynex Monitoring Solutions

Phone: (800) 495-6670

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place